Tez, M.Göçmen, E.Özçelik, T.2015-07-282015-07-282003-11-010140-6736http://hdl.handle.net/11693/11273EnglishAngiopoietinTransforming growth factor betaTrastuzumabVasculotropinEpidermal Growth Factor Receptor 2Interstitial CollagenaseMonoclonal AntibodyVasculotropin AAngiogenesisAntigen ExpressionBreast CarcinomaCancer SurgeryCarcinoma CellCell ProliferationGene OverexpressionGrowth StimulationHumanLetterMetastasisPhysiologyPriority JournalTumorTumor growthWoundBreast tumorCell divisionFemaleGene expression regulationGeneticsNotePathophysiologyProto oncogeneStructure activity relationCarcinoma in situDrug antagonismNeovascularization (pathology)Breast neoplasmsCell divisionFemaleGene expression regulationNeoplasticGenesErbb-2HumansMatrix metalloproteinase 1ReceptorErbb-2Structure-activity relationshipAntibodiesMonoclonalBreast neoplasmsCarcinoma in situNeovascularizationPathologicVascular endothelial growth factor AHER2 and proliferation of wound-induced breast carcinomaArticle10.1016/S0140-6736(03)14707-1